Orforglipron
A Study of Orforglipron (LY3502970) in Adolescent Participants With Obesity, or Overweight With Related Comorbidities
Eli Lilly · Phase 3 · Recruiting · Enrollment 150
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Orforglipron | Obesity or overweight | n/r | 156 | n/r | n/r |
| Placebo | Obesity or overweight | n/r | 156 | n/r | n/r |